BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Business

  Rubius Therapeutics Strengthens Leadership Team With Appointment of Andrew Oh as Chief Financial Officer

  Mr. Oh brings to Rubius more than 20 years of experience in finance and the biopharmaceutical industry.

  December 14, 2017

   · 

  3 min read
• 

  FDA

  gel-e Wins FDA OK to Expand its Bandage Product Line for Rx and OTC Use

  gel-e announces the 510(k) clearance of its adhesive bandage by the FDA for prescription and OTC use.

  December 14, 2017

   · 

  2 min read
• Pharm Country

  Mylan Announces the U.S. Patent and Trademark Appeal Board Institutes Inter Partes Review Proceedings on All Claims Against Sanofi’s Lantus Patents

  Mylan today announced that the U.S. PTAB has instituted IPR proceedings on all claims against two Orange Book-listed patents, U.S. Patent Nos. 7,476,652 and 7,713,930, owned by Sanofi for Lantus 100 Units/mL.

  December 14, 2017

   · 

  4 min read
• Business

  Nuvo Pharma Enters Into Pennsaid 2% License Agreement With Gebro Pharma AG for Switzerland and Liechtenstein

  The License Agreement grants Gebro Pharma the exclusive rights throughout the Territory to register, market, sell and distribute Pennsaid 2% as a non-prescription drug for the human treatment of osteoarthritis of the knee and acute pain from sprains and strains.

  December 14, 2017

   · 

  5 min read
• 

  INSIGHTEC Gets a $150M Boost From Koch Disruptive Technologies

  The medical device company is transforming neurological treatments through its non-invasive focused ultrasound applications.

  December 14, 2017

   · 

  4 min read
• Business

  KalVista Pharmaceuticals Reports Fiscal Second Quarter Results

  Revenue was $1.1 million for the three months ended October 31, 2017, compared to $0.2 million for the same period in 2016.

  December 14, 2017

   · 

  8 min read
• Drug Development

  Pfizer Initiates Phase III Program for PF-04965842, a JAK1 Inhibitor in Development for Moderate-to-Severe Atopic Dermatitis

  The design of the Phase 3 trial is based on the Phase 2 results that were presented at the 26th Congress of the European Academy of Dermatology and Venereology in September 2017.

  December 14, 2017

   · 

  6 min read
• MediaTek Sensio: New Biosensor Solution Brings Health Monitoring to Smartphones

  MediaTek Sensio is a powerful advanced health monitoring solution which makes it easy to track heart rate information, blood pressure trends, peripheral oxygen saturation levels and more.

  December 14, 2017

   · 

  4 min read
• Drug Development

  Trovagene Submits Protocol to FDA for Phase II Clinical Trial of PCM-075 in Combination With Zytiga for Metastatic Castration-Resistant Prostate Cancer

  In this multi-center, open-label, Phase 2 trial, PCM-075 in combination with the standard dose of abiraterone and prednisone, all administered orally, will be evaluated for safety and efficacy.

  December 14, 2017

   · 

  8 min read
• Biotech Beach

  Tocagen Added to NASDAQ Biotechnology Index

  Tocagen today announced it has been selected for addition to the NASDAQ Biotechnology Index, which will become effective prior to the open of U.S. markets on Monday, December 18, 2017.

  December 14, 2017

   · 

  1 min read